K. Oyama

Cyclooxygenase-2 expression in hepatocellular carcinoma.

H. Kawasaki, K. Yashima, G. Shiota, 1999, Hepato-gastroenterology.

Occult hepatitis B virus infection in HBs antigen‐negative hepatocellular carcinoma in a Japanese population: Involvement of HBx and p53

H. Kawasaki, K. Yashima, G. Shiota, 2000, Journal of medical virology.

In vivo transfer of hepatocyte growth factor gene accelerates proliferation of hepatic oval cells in a 2‐acetylaminofluorene/partial hepatectomy model in rats

T. Nakamura, H. Kawasaki, S. Sell, 2000, FEBS letters.

Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma

H. Kawasaki, Y. Murawaki, M. Koda, 2001, Cancer.

Molischpositive mucopolysaccharides of gastric cancers as compared with the corresponding components of gastric mucosae. 1. Fractionation procedure of gastric cancer and gastric mucosa.

H. Kawasaki, K. Oyama, Y. Yamaguchi, 1958, The Tohoku journal of experimental medicine.

Severe exacerbation of hepatitis after short-term corticosteroid therapy in a patients with "latent" chronic hepatitis B.

H. Kawasaki, K. Harada, G. Shiota, 2000, Liver.

Clinical significance of serum soluble Fas ligand in patients with acute self-limited and fulminant hepatitis.

H. Kawasaki, G. Shiota, N. Noguchi, 1998, Research communications in molecular pathology and pharmacology.